BioChaga is a sublimated birch fungus chaga extract with proven antitumor and immunomodulatory effects, which is produced according to the author’s unique technology
DOI: https://doi.org/10.29296/25877305-2022-03-14
Issue:
3
Year:
2022
The paper reviews Russian and foreign scientific publications that reflect the issues of using
chaga (Polyporus sulphureus) in clinical practice. It shows the features of the physicochemical composition
of a sublimated BioChaga extract and presents the efficiency of using BioChaga extract in oncology. The
antitumor, immunomodulatory, detoxifying, and anti-inflammatory effects of the extract are noted.
Keywords:
therapy
chaga extract
BioChaga
antitumor
immunomodulatory
detoxifying effects
production technology
Inonotus obliquus
References:
- Zmitrovich I.V., Denisova N.P., Balandajkin M.E. i dr. Chaga i ee bioaktivnye kompleksy: istorija i perspektivy. Formuly Farmatsii. 2020; 2 (2): 84–93. DOI: 10.17816/phf34803
- Sinkina T. Biodigidrokvertsetin (BDK) i Biochaga (BCh) kak soprovoditel'naja terapija pri himioterapevticheskom i posleoperatsionnom kurse distantsionnoj luchevoj terapii raka molochnoj zhelezy. Meditsina: tselevye proekty. 2020; 36: 28–30.
- Ganov D.I. Ispol'zovanie kachestvennyh prirodnyh BADov v kachestve soprovoditel'noj terapii pri radikal'nom luchevom lechenii i himioterapii onkourologicheskih patsientov. Vrach. 2021; 32 (11): 76–9. DOI: 10.29296/25877305-2021-11-16
- Duru K.C., Kovaleva E.G., Danilova I.G. et al. The pharmacological potential and possible molecular mechanisms of action of Inonotus obliquus from preclinical studies. Phytother Res. 2019; 33 (8): 1966–80. DOI: 10.1002/ptr.6384
- Eid J.I., Das B., Al-Tuwaijri M.M. et al. Targeting SARS-CoV-2 with Chaga mushroom: An in silico study toward developing a natural antiviral compound. Food Sci Nutr. 2021; 9 (12): 6513–23. DOI: 10.1002/fsn3.2576
- Zhao Y., Zheng W. Deciphering the antitumoral potential of the bioactive metabolites from medicinal mushroom Inonotus obliquus. J Ethnopharmacol. 2021; 265: 113321. DOI: 10.1016/j.jep.2020.113321
- Sousa J.L.C., Freire C.S.R., Silvestre A.J.D. et al. Recent Developments in the Functionalization of Betulinic Acid and Its Natural Analogues: A Route to New Bioactive Compounds. Molecules. 2019; 24 (2): 355. DOI: 10.3390/molecules24020355
- Zmitrovich I.V., Belova N.V., Balandaykin M.E. et al. Cancer without Pharmacological Illusions and a Niche for Mycotherapy (Review). Int J Med Mushrooms. 2019; 21 (2): 105–19. DOI: 10.1615/IntJMedMushrooms.2019030047
- Jöhrer K., Ҫiҫek S.S. Multiple Myeloma Inhibitory Activity of Plant Natural Products. Cancers (Basel). 2021; 13 (11): 2678. DOI: 10.3390/cancers13112678
- Zhao F., Mai Q., Ma J. et al. Triterpenoids from Inonotus obliquus and their antitumor activities. Fitoterapia. 2015; 101: 34–40. DOI: 10.1016/j.fitote.2014.12.005
- Kim Y.R. Immunomodulatory Activity of the Water Extract from Medicinal Mushroom Inonotus obliquus. Mycobiology. 2005; 33 (3): 158–62. DOI: 10.4489/MYCO.2005.33.3.158
- Szychowski K.A., Skóra B., Pomianek T. et al. Inonotus obliquus – from folk medicine to clinical use. J Tradit Complement Med. 2020; 11 (4): 293–302. DOI: 10.1016/j.jtcme.2020.08.003
- Baek J., Roh H.S., Baek K.H. et al. Bioactivity-based analysis and chemical characterization of cytotoxic constituents from Chaga mushroom (Inonotus obliquus) that induce apoptosis in human lung adenocarcinoma cells. J Ethnopharmacol. 2018; 224: 63–75. DOI: 10.1016/j.jep.2018.05.025
- Kumar P., Bhadauria A.S., Singh A.K. et al. Betulinic acid as apoptosis activator: Molecular mechanisms, mathematical modeling and chemical modifications. Life Sci. 2018; 209: 24–33. DOI: 10.1016/j.lfs.2018.07.056
- Wang X., Lu X., Zhu R. et al. Betulinic Acid Induces Apoptosis in Differentiated PC12 Cells Via ROS-Mediated Mitochondrial Pathway. Neurochem Res. 2017; 42 (4): 1130–40. DOI: 10.1007/s11064-016-2147-y
- Lu Y., Jia Y., Xue Z. et al. Recent Developments in Inonotus obliquus (Chaga mushroom) Polysaccharides: Isolation, Structural Characteristics, Biological Activities and Application. Polymers (Basel). 2021; 13 (9): 1441. DOI: 10.3390/polym13091441
- Nguyen T.M.N., Le H.S., Le B.V. et al. Anti-allergic effect of inotodiol, a lanostane triterpenoid from Chaga mushroom, via selective inhibition of mast cell function. Int Immunopharmacol. 2020; 81: 106244. DOI: 10.1016/j.intimp.2020.106244
- Maza P.A.M.A., Lee J.H., Kim Y.S. et al. Inotodiol From Inonotus obliquus Chaga Mushroom Induces Atypical Maturation in Dendritic Cells. Front Immunol. 2021; 12: 650841. DOI: 10.3389/fimmu.2021.650841
- Kou R.W., Han R., Gao Y.Q. et al. Anti-neuroinflammatory polyoxygenated lanostanoids from Chaga mushroom Inonotus obliquus. Phytochemistry. 2021; 184: 112647. DOI: 10.1016/j.phytochem.2020.112647
- Ali-Seyed M., Jantan I., Vijayaraghavan K. et al. Betulinic Acid: Recent Advances in Chemical Modifications, Effective Delivery, and Molecular Mechanisms of a Promising Anticancer Therapy. Chem Biol Drug Des. 2016; 87 (4): 517–36. DOI: 10.1111/cbdd.12682
- Spivak A.Y., Nedopekina D.A., Gubaidullin R.R. et al. Conjugation of Natural Triterpenic Acids with Delocalized Lipophilic Cations: Selective Targeting Cancer Cell Mitochondria. J Pers Med. 2021; 11 (6): 470. DOI: 10.3390/jpm11060470
- Alzand K.I., Ünal S., Boufaris M.S.M. Lanostane-Type Triterpenes and Abietane-Type Diterpene from the Sclerotia of Chaga Medicinal Mushroom, Inonotus obliquus (Agaricomycetes), and Their Biological Activities. Int J Med Mushrooms. 2018; 20 (6): 507–16. DOI: 10.1615/IntJMedMushrooms.2018026007
- Nikitina S.A., Khabibrakhmanova V.R., Sysoeva M.A. Composition and biological activity of triterpenes and steroids from Inonotus obliquus (chaga). Biomed Khim. 2016; 62 (4): 369–75. DOI: 10.18097/PBMC20166204369
- Zou C.X., Dong S.H., Hou Z.L. et al. Modified lanostane-type triterpenoids with neuroprotective effects from the fungus Inonotus obliquus. Bioorg Chem. 2020; 105: 104438. DOI: 10.1016/j.bioorg.2020.104438
- Wei Y.M., Yang L., Mei W.L. et al. Phenolic compounds from the sclerotia of Inonotus obliquus. Nat Prod Res. 2020: 1–5. DOI: 10.1080/14786419.2020.1833202
- Zou C.X., Zhang Y.Y., Bai M. et al. Aromatic compounds from the sclerotia of Inonotus obliquus. Nat Prod Res. 2021; 35 (14): 2454–7. DOI: 10.1080/14786419.2019.1677656
- Živković L., Bajić V., Topalović D. et al. Antigenotoxic Effects of Biochaga and Dihydroquercetin (Taxifolin) on H2O2-Induced DNA Damage in Human Whole Blood Cells. Oxid Med Cell Longev. 2019; 2019: 5039372. DOI: 10.1155/2019/5039372
- Zmitrovich I.V., Denisova N.P., Balandaykin M.E. et al. Chaga and its bioactive complexes: history and perspectives. Pharmacy Formulas. 2020; 2 (2): 84–93 (in Russ.). DOI: 10.17816/phf34803
- Sinkina T. Biodigidrokvertsetin (BDK) i Biochaga (BCh) kak soprovoditel’naya terapiya pri khimioterapevticheskom i posleoperatsionnom kurse distantsionnoi luchevoi terapii raka molochnoi zhelezy. Meditsina: tselevye proekty. 2020; 36: 28–30
- Ganov D. Use of high-quality natural dietary supplements as accompanying therapy in patients during radical radiotherapy and chemotherapy for urological cancer. Vrach. 2021; 32 (11): 76–9. DOI: 10.29296/25877305-2021-11-16
- Duru K.C., Kovaleva E.G., Danilova I.G. et al. The pharmacological potential and possible molecular mechanisms of action of Inonotus obliquus from preclinical studies. Phytother Res. 2019; 33 (8): 1966–80. DOI: 10.1002/ptr.6384
- Eid J.I., Das B., Al-Tuwaijri M.M. et al. Targeting SARS-CoV-2 with Chaga mushroom: An in silico study toward developing a natural antiviral compound. Food Sci Nutr. 2021; 9 (12): 6513–23. DOI: 10.1002/fsn3.2576
- Zhao Y., Zheng W. Deciphering the antitumoral potential of the bioactive metabolites from medicinal mushroom Inonotus obliquus. J Ethnopharmacol. 2021; 265: 113321. DOI: 10.1016/j.jep.2020.113321
- Sousa J.L.C., Freire C.S.R., Silvestre A.J.D. et al. Recent Developments in the Functionalization of Betulinic Acid and Its Natural Analogues: A Route to New Bioactive Compounds. Molecules. 2019; 24 (2): 355. DOI: 10.3390/molecules24020355
- Zmitrovich I.V., Belova N.V., Balandaykin M.E. et al. Cancer without Pharmacological Illusions and a Niche for Mycotherapy (Review). Int J Med Mushrooms. 2019; 21 (2): 105–19. DOI: 10.1615/IntJMedMushrooms.2019030047
- Jöhrer K., Ҫiҫek S.S. Multiple Myeloma Inhibitory Activity of Plant Natural Products. Cancers (Basel). 2021; 13 (11): 2678. DOI: 10.3390/cancers13112678
- Zhao F., Mai Q., Ma J. et al. Triterpenoids from Inonotus obliquus and their antitumor activities. Fitoterapia. 2015; 101: 34–40. DOI: 10.1016/j.fitote.2014.12.005
- Kim Y.R. Immunomodulatory Activity of the Water Extract from Medicinal Mushroom Inonotus obliquus. Mycobiology. 2005; 33 (3): 158–62. DOI: 10.4489/MYCO.2005.33.3.158
- Szychowski K.A., Skóra B., Pomianek T. et al. Inonotus obliquus – from folk medicine to clinical use. J Tradit Complement Med. 2020; 11 (4): 293–302. DOI: 10.1016/j.jtcme.2020.08.003
- Baek J., Roh H.S., Baek K.H. et al. Bioactivity-based analysis and chemical characterization of cytotoxic constituents from Chaga mushroom (Inonotus obliquus) that induce apoptosis in human lung adenocarcinoma cells. J Ethnopharmacol. 2018; 224: 63–75. DOI: 10.1016/j.jep.2018.05.025
- Kumar P., Bhadauria A.S., Singh A.K. et al. Betulinic acid as apoptosis activator: Molecular mechanisms, mathematical modeling and chemical modifications. Life Sci. 2018; 209: 24–33. DOI: 10.1016/j.lfs.2018.07.056
- Wang X., Lu X., Zhu R. et al. Betulinic Acid Induces Apoptosis in Differentiated PC12 Cells Via ROS-Mediated Mitochondrial Pathway. Neurochem Res. 2017; 42 (4): 1130–40. DOI: 10.1007/s11064-016-2147-y
- Lu Y., Jia Y., Xue Z. et al. Recent Developments in Inonotus obliquus (Chaga mushroom) Polysaccharides: Isolation, Structural Characteristics, Biological Activities and Application. Polymers (Basel). 2021; 13 (9): 1441. DOI: 10.3390/polym13091441
- Nguyen T.M.N., Le H.S., Le B.V. et al. Anti-allergic effect of inotodiol, a lanostane triterpenoid from Chaga mushroom, via selective inhibition of mast cell function. Int Immunopharmacol. 2020; 81: 106244. DOI: 10.1016/j.intimp.2020.106244
- Maza P.A.M.A., Lee J.H., Kim Y.S. et al. Inotodiol From Inonotus obliquus Chaga Mushroom Induces Atypical Maturation in Dendritic Cells. Front Immunol. 2021; 12: 650841. DOI: 10.3389/fimmu.2021.650841
- Kou R.W., Han R., Gao Y.Q. et al. Anti-neuroinflammatory polyoxygenated lanostanoids from Chaga mushroom Inonotus obliquus. Phytochemistry. 2021; 184: 112647. DOI: 10.1016/j.phytochem.2020.112647
- Ali-Seyed M., Jantan I., Vijayaraghavan K. et al. Betulinic Acid: Recent Advances in Chemical Modifications, Effective Delivery, and Molecular Mechanisms of a Promising Anticancer Therapy. Chem Biol Drug Des. 2016; 87 (4): 517–36. DOI: 10.1111/cbdd.12682
- Spivak A.Y., Nedopekina D.A., Gubaidullin R.R. et al. Conjugation of Natural Triterpenic Acids with Delocalized Lipophilic Cations: Selective Targeting Cancer Cell Mitochondria. J Pers Med. 2021; 11 (6): 470. DOI: 10.3390/jpm11060470
- Alzand K.I., Ünal S., Boufaris M.S.M. Lanostane-Type Triterpenes and Abietane-Type Diterpene from the Sclerotia of Chaga Medicinal Mushroom, Inonotus obliquus (Agaricomycetes), and Their Biological Activities. Int J Med Mushrooms. 2018; 20 (6): 507–16. DOI: 10.1615/IntJMedMushrooms.2018026007
- Nikitina S.A., Khabibrakhmanova V.R., Sysoeva M.A. Composition and biological activity of triterpenes and steroids from Inonotus obliquus (chaga). Biomed Khim. 2016; 62 (4): 369–75. DOI: 10.18097/PBMC20166204369
- Zou C.X., Dong S.H., Hou Z.L. et al. Modified lanostane-type triterpenoids with neuroprotective effects from the fungus Inonotus obliquus. Bioorg Chem. 2020; 105: 104438. DOI: 10.1016/j.bioorg.2020.104438
- Wei Y.M., Yang L., Mei W.L. et al. Phenolic compounds from the sclerotia of Inonotus obliquus. Nat Prod Res. 2020: 1–5. DOI: 10.1080/14786419.2020.1833202
- Zou C.X., Zhang Y.Y., Bai M. et al. Aromatic compounds from the sclerotia of Inonotus obliquus. Nat Prod Res. 2021; 35 (14): 2454–7. DOI: 10.1080/14786419.2019.1677656
- Živković L., Bajić V., Topalović D. et al. Antigenotoxic Effects of Biochaga and Dihydroquercetin (Taxifolin) on H2O2-Induced DNA Damage in Human Whole Blood Cells. Oxid Med Cell Longev. 2019; 2019: 5039372. DOI: 10.1155/2019/5039372